Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: An open-label, multicenter study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: An open-label, multicenter study

Published:2001-06 Issue:6 Volume:50 Page:729-733
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Aguilar-Salinas Carlos Alberto,Fangh[auml ]nel-Salm[oacute]n Guillermo,Meza Edilberto,Montes Juan,Gul[iacute]as-Herrero Alfonso,S[aacute]nchez Leticia,Monterrubio-Flores Eric A.,Gonz[aacute]lez-Valdez H[eacute]ctor,P[eacute]rez Francisco J.G[oacute]mez

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of Obesity and Metabolic Syndrome;Metabolic Syndrome;2023

2. Pharmacotherapy of Obesity and Metabolic Syndrome;Metabolic Syndrome;2023

3. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease;Endocrine Practice;2017-04

4. Fibrates for primary prevention of cardiovascular disease events;Cochrane Database of Systematic Reviews;2016-11-16

5. Fibrates;Clinical Lipidology;2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP